Childhood trauma and insulin resistance in patients suffering from depressive disorders

Experimental Neurology

Volumn 315, Issue , 2019, Pages 15-20

  Nasca, Carla ^a   Watson Lin, Kathleen ^b   Bigio, Benedetta ^a   Robakis, Thalia K ^b   Myoraku, Alison ^b   Wroolie, Tonita E ^b   McEwen, Bruce S ^a   Rasgon, Natalie ^a,b  

^a ROCKEFELLER UNIVERSITY   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Childhood stress; Emotional abuse; Family history of type 2 diabetes; Insulin resistance; Insulin secretion; Risk factors

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CHILD NEGLECT; CHILD SEXUAL ABUSE; CHILDHOOD TRAUMA; CLINICAL ARTICLE; DISEASE SEVERITY; EMOTIONAL NEGLECT; FASTING; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR DEPRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ABUSE; PRIORITY JOURNAL; BLOOD; CHILD; CHILD ABUSE; FAMILY; FEMALE; GENETICS; GLUCOSE TOLERANCE TEST; MALE; METABOLISM; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CHILD; CHILD ABUSE; DEPRESSIVE DISORDER, MAJOR; DIABETES MELLITUS, TYPE 2; FAMILY; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES;

EID: 85060953679     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2019.01.005     Document Type: Article

References (43)

1. Austin, A.W., et al. Differential association of insulin resistance with cognitive and somatic symptoms of depression. Diabet. Med. 31:8 (2014), 994–1000.
2. Bernstein, D.P., et al. Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abuse Negl. 27:2 (2003), 169–190.
3. Bigio, B., et al. Epigenetics and energetics in ventral hippocampus mediate rapid antidepressant action: Implications for treatment resistance. Proc. Natl. Acad. Sci. U. S. A. 113:28 (2016), 7906–7911.
4. Danese, A., et al. Adverse childhood experiences and adult risk factors for age-related disease: depression, inflammation, and clustering of metabolic risk markers. Arch. Pediatr. Adolesc. Med. 163:12 (2009), 1135–1143.
5. Daskalakis, N.P., Bagot, R.C., Parker, K.J., Vinkers, C.H., de Kloet, E.R., The three-hit concept of vulnerability and resilience: toward understanding adaptation to early-life adversity outcome. Psychoneuroendocrinology 38:9 (2013), 1858–1873.
6. De Felice, F.G., Ferreira, S.T., Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease. Diabetes 63:7 (2014), 2262–2272.
7. Fan, C.A., et al. The effect of family history of diabetes on sleep quality, depression, and anxiety in adult males with diabetes. J. Diabetes Mellitus, 03(01), 2013, 4.
8. Fletcher, B., Gulanick, M., Lamendola, C., Risk factors for type 2 diabetes mellitus. J. Cardiovasc. Nurs. 16:2 (2002), 17–23.
9. Fritz, I.B., McEwen, B.S., Effects of carnitine on fatty-acid oxidation by muscle. Science 129:3345 (1959), 334–335.
10. Kenna, H., et al. Fasting plasma insulin and the default mode network in women at risk for Alzheimer's disease. Neurobiol. Aging 34:3 (2013), 641–649.
11. Kiraly, D.D., et al. Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome. Transl. Psychiatry, 7(3), 2017, e1065.
12. Kullmann, S., et al. The obese brain: association of body mass index and insulin sensitivity with resting state network functional connectivity. Hum. Brain Mapp. 33:5 (2012), 1052–1061.
13. Li, L., Garvey, W.T., Gower, B.A., Childhood maltreatment is an independent risk factor for prediabetic disturbances in glucose regulation. Front. Endocrinol., 8, 2017, 151.
14. Lin, K.W., Wroolie, T.E., Robakis, T., Rasgon, N.L., Adjuvant pioglitazone for unremitted depression: clinical correlates of treatment response. Psychiatry Res. 230:3 (2015), 846–852.
15. Lyons, D.M., Parker, K.J., Stress inoculation-induced indications of resilience in monkeys. J. Trauma. Stress. 20:4 (2007), 423–433.
16. Lyons, D.M., Parker, K.J., Katz, M., Schatzberg, A.F., Developmental cascades linking stress inoculation, arousal regulation, and resilience. Front. Behav. Neurosci., 3, 2009, 32.
17. Lyons, D.M., Parker, K.J., Schatzberg, A.F., Animal models of early life stress: implications for understanding resilience. Dev. Psychobiol. 52:7 (2010), 616–624.
18. Matsuda, M., DeFronzo, R.A., Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:9 (1999), 1462–1470.
19. McEwen, B.S., Stress, adaptation, and disease. Allostasis and allostatic load. Ann. N. Y. Acad. Sci. 840 (1998), 33–44.
20. McEwen, B.S., Wingfield, J.C., The concept of allostasis in biology and biomedicine. Horm. Behav. 43:1 (2003), 2–15.
21. McEwen, B.S., et al. Mechanisms of stress in the brain. Nat. Neurosci. 18:10 (2015), 1353–1363.
22. McEwen, B.S., Nasca, C., Gray, J.D., Stress effects on neuronal structure: hippocampus, amygdala, and prefrontal cortex. Neuropsychopharmacology 41:1 (2016), 3–23.
23. McIntyre, R.S., et al. Metabolic syndrome and major depressive disorder: co-occurrence and pathophysiologic overlap. Curr. Diabetes Rep. 9:1 (2009), 51–59.
24. Mortimer, J.T., Staff J, Early work as a source of developmental discontinuity during the transition to adulthood. Dev. Psychopathol. 16:4 (2004), 1047–1070.
25. Nasca, C., et al. ACNP 56th Annual meeting: panels, mini-panels and study groups, December 4–7, 2017. Neuropsychopharmacology, 42(S1), 2017.
26. Nasca, C., et al. Role of the astroglial glutamate exchanger xCT in ventral hippocampus in resilience to stress. Neuron 96:2 (2017), 402–413 (e405).
27. Nasca, C., Rasgon, N., McEwen, B., An emerging epigenetic framework of systemic and central mechanisms underlying stress-related disorders. Neuropsychopharmacology 44:1 (2019 Jan), 235–236, 10.1038/s41386-018-0227-1.
28. Nasca, C., et al. Acetyl-l-carnitine deficiency in patients with major depressive disorder. Proc. Natl. Acad. Sci. U S A. 115:34 (2018 Aug 21), 8627–8632, 10.1073/pnas.1801609115.
29. Nemeroff, C.B., Paradise lost: the neurobiological and clinical consequences of child abuse and neglect. Neuron 89:5 (2016), 892–909.
30. Parker, K.J., Buckmaster, C.L., Sundlass, K., Schatzberg, A.F., Lyons, D.M., Maternal mediation, stress inoculation, and the development of neuroendocrine stress resistance in primates. Proc. Natl. Acad. Sci. U. S. A. 103:8 (2006), 3000–3005.
31. Post, R.M., Myriad of implications of acetyl-l-carnitine deficits in depression. Proc. Natl. Acad. Sci. U. S. A. 115:34 (2018), 8475–8477.
32. Post RM, et al. (Role of Childhood Adversity in the Development of Medical Co-Morbidities Associated with Bipolar Disorder. (1573–2517 (Electronic)).
33. Raison, C.L., Capuron, L., Miller, A.H., Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 27:1 (2006), 24–31.
34. Rasgon, N., Jarvik, L., Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis. J. Gerontol. 59:2 (2004), 178–183 Series A, Biological sciences and medical sciences. (discussion 184-192).
35. Rasgon, N.L., McEwen, B.S., Insulin resistance-a missing link no more. Mol. Psychiatry 21:12 (2016), 1648–1652.
36. Rasgon, N.L., et al. Metabolic dysfunction in women with bipolar disorder: the potential influence of family history of type 2 diabetes mellitus. Bipolar Disord. 12:5 (2010), 504–513.
37. Rasgon, N.L., et al. Rosiglitazone add-on in treatment of depressed patients with insulin resistance: a pilot study. TheScientificWorldJOURNAL 10 (2010), 321–328.
38. Rasgon, N.L., et al. Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease. Neurobiol. Aging 32:11 (2011), 1942–1948.
39. Stemmle, P.G., et al. Insulin resistance and hyperlipidemia in women with bipolar disorder. J. Psychiatr. Res. 43:3 (2009), 341–343.
40. Tsuno, N., Besset, A., Ritchie, K., Sleep and depression. J. Clin. Psychiatry 66:10 (2005), 1254–1269.
41. Watson, K., Nasca, C., Aasly, L., McEwen, B., Rasgon, N., Insulin resistance, an unmasked culprit in depressive disorders: promises for interventions. Neuropharmacology 136:Pt B (2018 Jul 1), 327–334, 10.1016/j.neuropharm.2017.11.038.
42. Williams, L.M., Debattista, C., Duchemin, A.M., Schatzberg, A.F., Nemeroff, C.B., Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression. Transl. Psychiatry, 6, 2016, e799.
43. Wroolie, T.E., Kenna, H.A., Singh, M.K., Rasgon, N.L., Association between insulin resistance and cognition in patients with depressive disorders: exploratory analyses into age-specific effects. J. Psychiatr. Res. 60 (2015), 65–72.